The difference in the study population in terms of the severity of COVID-19, and on the other hand, other factors affecting the mortality of COVID-19 patients, such as concurrent diseases, high levels of inflammatory factors such as interleukin-6 (IL-6), can be the reason for the difference between the results of this study and other studies [24, 25]. The gene discussed is IL6; the disease is COVID-19.